SQZ Biotechnologies Company (SQZB)
OTCMKTS · Delayed Price · Currency is USD
0.0280
0.00 (0.00%)
May 12, 2025, 4:00 PM EDT

SQZB Statistics

Total Valuation

SQZB has a market cap or net worth of 825,752.

Market Cap 825,752
Enterprise Value n/a

Important Dates

The last earnings date was Friday, May 9, 2025.

Earnings Date May 9, 2025
Ex-Dividend Date n/a

Share Statistics

SQZB has 29.49 million shares outstanding.

Current Share Class 29.49M
Shares Outstanding 29.49M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 2.10%
Owned by Institutions (%) 13.34%
Float 26.14M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.07
PB Ratio 0.44
P/TBV Ratio 0.44
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.37, with a Debt / Equity ratio of 11.42.

Current Ratio 1.37
Quick Ratio 1.15
Debt / Equity 11.42
Debt / EBITDA n/a
Debt / FCF -0.29
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -203.37% and return on invested capital (ROIC) is -49.20%.

Return on Equity (ROE) -203.37%
Return on Assets (ROA) -41.14%
Return on Invested Capital (ROIC) -49.20%
Return on Capital Employed (ROCE) -289.97%
Revenue Per Employee 228,698
Profits Per Employee -1.35M
Employee Count 53
Asset Turnover 0.13
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +5.66% in the last 52 weeks. The beta is 1.40, so SQZB's price volatility has been higher than the market average.

Beta (5Y) 1.40
52-Week Price Change +5.66%
50-Day Moving Average 0.03
200-Day Moving Average 0.03
Relative Strength Index (RSI) 42.82
Average Volume (20 Days) 1,449

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 3.88

Income Statement

In the last 12 months, SQZB had revenue of 12.12 million and -71.64 million in losses. Loss per share was -2.43.

Revenue 12.12M
Gross Profit -39.67M
Operating Income -60.77M
Pretax Income -71.64M
Net Income -71.64M
EBITDA -59.06M
EBIT -60.77M
Loss Per Share -2.43
Full Income Statement

Balance Sheet

The company has 10.19 million in cash and 21.47 million in debt, giving a net cash position of -11.28 million or -0.38 per share.

Cash & Cash Equivalents 10.19M
Total Debt 21.47M
Net Cash -11.28M
Net Cash Per Share -0.38
Equity (Book Value) 1.88M
Book Value Per Share 0.06
Working Capital 3.26M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -74.33 million and capital expenditures -213,000, giving a free cash flow of -74.55 million.

Operating Cash Flow -74.33M
Capital Expenditures -213,000
Free Cash Flow -74.55M
FCF Per Share -2.53
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -501.34%
Pretax Margin -591.07%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SQZB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.56%
Shareholder Yield -3.56%
Earnings Yield -8,676.09%
FCF Yield -9,027.77%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

SQZB has an Altman Z-Score of -21.28. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -21.28
Piotroski F-Score n/a